Is medication use by community-dwelling elderly people influenced by cognitive function?

Age and Ageing

Volumn 25, Issue 3, 1996, Pages 190-196

  Hanlon, Joseph T ^a   Landerman, Lawrence R ^a   Wall Jr , William E ^a   Horner, Ronnie D ^a   Fillenbaum, Gerda G ^a   Dawson, Deborah V ^a,b   Schmader, Kenneth E ^a   Cohen, Harvey Jay ^a   Blazer, Dan G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MALE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL POPULATION; SENESCENCE; UNITED STATES; URBAN POPULATION;

ACTIVITIES OF DAILY LIVING; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANALGESICS; CENTRAL NERVOUS SYSTEM AGENTS; DATA COLLECTION; DEMENTIA; DRUG UTILIZATION REVIEW; DRUGS, NON-PRESCRIPTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MULTIVARIATE ANALYSIS; NORTH CAROLINA; PRESCRIPTIONS, DRUG; SAMPLING STUDIES;

EID: 0029878983     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/25.3.190     Document Type: Article

References (41)

1. Lipton HL, Lee PR, eds. Drugs and the elderly: clinical, social, and policy perspectives. Stanford: Stanford University Press, 1988.
2. Nolan L, O'Malley K. Prescribing for the elderly: Part II. Prescribing patterns: differences due to age. J Am Geriatr Soc 1988;36:245-54.
3. Hanlon JT, Fillenbaum GG, Burchett B, et al. Drug use patterns in black and nonblack community dwelling elderly. Ann Pharmacother 1992;26:679-85.
4. Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE, Brock D. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health 1993;83:1577-82.
5. Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, Cornoni-Huntley J. Medication use characteristics in the elderly: the Iowa 65 + Rural Health Study. J Am Geriatr Soc 1987;35:4-12.
6. Hale WE, May FE, Marks RG, Stewart RB. Drug use in an ambulatory elderly population: a five-year update. Drug Intell Clin Pharm 1987;21:530-5.
7. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol 1992;47:M137-44.
8. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for community dwelling elderly. JAMA 1994;272:292-6.
9. Pulliam CC, Hanlon JT, Moore SR. Contemporary issues in geriatric drug therapy. J Geriatr Drug Ther 1989;4:43-86.
10. Hanlon JT, Schmader K, Lewis I. Adverse drug reactions. In: Delafuente JC, Stewart RB, eds. Therapeutics in the elderly. 2nd edn. Cincinnati: Harvey Whitney Books, 1994;212-27.
11. Kumar V, Salama AA, Desai B, Kumar N. A community survey: drug prescribing in dementia and in normal elderly. Am J Alzheimer's Care Relat Disord Res 1988;3(3):16-20.
12. Wolf-Klein GP, Silverstone FA, Brod MS, et al. Are Alzheimer patients healthier? J Am Geriatr Soc 1988;36: 219-24.
13. Semla TP, Cohen D, Paveza G, et al. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. J Am Geriatr Soc 1993;41:408-13.
14. Colsher PL, Wallace RB. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol Rev 1991;13:1-27.
15. Regier DA, Boyd JH, Burke JD, et al. One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 1988;45:977-86.
16. Morrison RL, Katz IR. Drug-related cognitive impairment: current progress and recurrent problems. Annu Rev Gerontol Geriatr 1989;9:232-79.
17. Stewart RB, Hale WE. Acute confusional states in older adults and the role of polypharmacy. Annu Rev Public Health 1992;13:415-30.
18. Lowenthal DT, Nadeau SE. Drug-induced dementia. South Med J 1991;84(5S1):24-31.
19. Bowen JD, Larson EB. Drug-induced cognitive impairment: defining the problem and finding solutions. Drugs Aging 1993;3:349-57.
20. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Int Med 1987;107:169-73.
21. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-63.
22. Sky AJ, Grossberg GT. The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease. Med Clin North Am 1994;78:811-22.
23. Wragg RE, Jeste DV. Neuroleptics and alternative treatments: management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions. Psychiatr Clin North Am 1988;11:195-213.
24. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-91.
25. Whitehouse PJ, Geldmacher DS. Pharmacotherapy for Alzheimer's disease. Clin Geriatr Med 1994;10:339-50.
26. Pharmaceutical Manufacturers' Association. New medicines in development for older Americans. 1993;2.
27. Cornoni-Huntley J, Blazer DG, Lafferty ME, Everett DF, Brock DB, Farmer ME, eds. Established populations for epidemiologic studies of the elderly. Vol 2. Resource data book (NIH Publication 90-495). Bethesda, Md.: National Institute on Aging, 1990.
28. DeVito CA, Aldridge GW, Wilson A, et al. Framework and development of a comprehensive drug product coding system. Contemp Pharm Pract 1979;2:62-5.
29. McEvoy GK, ed. AHFS Drug Information 1992. Bethesda: American Society of Hospital Pharmacists, 1992.
30. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficits in elderly patients. J Am Geriatr Soc 1975;23:433-41.
31. Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol 1966;21:556-9.
32. Rosner B. Fundamentals of biostatistics. 3rd edn. Boston: PWS-Kent Co., 1990.
33. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd rev. edn. Boston: PWS-Kent Co., 1988.
34. Dixon WJ, ed. BMDP statistical software. Berkeley: University of California Press, 1983.
35. SAS/STAT user's guide. Cary, NC: SAS Institute, 1993.
36. SUDAAN: professional software for survey data analysis. Research Triangle Park NC: Research Triangle Institute, 1989.
37. Ferrell BA. Pain management in elderly people. J Am Geriatr Soc 1991;39:64-73.
38. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer's disease. Lancet 1990;335:1037.
39. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
40. May FE, Moore MT, Stewart RB, Hale WE. Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly. Gerontology 1992;38:275-9.
41. Fillenbaum G, Heyman A, Williams K, Prosnitz B, Burchett B. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol 1990;43:651-60.